Orthofix Medical Inc. (NASDAQ:OFIX – Get Rating) insider Kevin J. Kenny sold 4,367 shares of Orthofix Medical stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $19.00, for a total transaction of $82,973.00. Following the transaction, the insider now owns 146,307 shares in the company, valued at $2,779,833. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Orthofix Medical Stock Down 0.4 %
NASDAQ OFIX traded down $0.08 during trading on Friday, reaching $18.86. The company’s stock had a trading volume of 161,286 shares, compared to its average volume of 340,905. The stock has a market capitalization of $689.14 million, a PE ratio of -7.61 and a beta of 0.87. Orthofix Medical Inc. has a 1-year low of $13.76 and a 1-year high of $27.91. The business has a 50-day moving average price of $17.95 and a 200-day moving average price of $19.02. The company has a current ratio of 2.98, a quick ratio of 1.37 and a debt-to-equity ratio of 0.10.
Orthofix Medical (NASDAQ:OFIX – Get Rating) last posted its earnings results on Monday, March 6th. The medical device company reported $0.19 EPS for the quarter, topping the consensus estimate of ($0.37) by $0.56. Orthofix Medical had a negative return on equity of 2.14% and a negative net margin of 14.40%. The business had revenue of $122.23 million during the quarter, compared to the consensus estimate of $121.90 million. During the same quarter last year, the company earned $0.27 EPS. On average, research analysts forecast that Orthofix Medical Inc. will post -2.89 earnings per share for the current fiscal year.
Institutional Trading of Orthofix Medical
Wall Street Analyst Weigh In
Separately, StockNews.com initiated coverage on shares of Orthofix Medical in a research report on Sunday, May 21st. They set a “buy” rating on the stock.
Orthofix Medical Company Profile
Orthofix Medical, Inc engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion.
- Get a free copy of the StockNews.com research report on Orthofix Medical (OFIX)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.